CMV and EBV-PTLD after liver transplantation.
So
S
S
Department of Surgery, Stanford University School of Medicine, Stanford, California, USA.
D000998:Antiviral Agents / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000209:etiology / Q000517:prevention & control*; D020031:Epstein-Barr Virus Infections / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D016867:Immunocompromised Host; D016031:Liver Transplantation
D000998:Antiviral Agents